Vasculitis syndromes: Not losing sight is the issue in GCA management

Nature Reviews Rheumatology

Volumn 6, Issue 8, 2010, Pages 440-441

  González Gay, Miguel A ^a   Rodríguez Valverde, Vicente ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE;

AORTA ANEURYSM; BLINDNESS; BLOOD VESSEL BIOPSY; CORTICOSTEROID THERAPY; DIAGNOSTIC IMAGING; DRUG DOSE REDUCTION; DRUG MEGADOSE; EARLY DIAGNOSIS; ERYTHROCYTE SEDIMENTATION RATE; GIANT CELL ARTERITIS; HEADACHE; HUMAN; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RELAPSE; RHEUMATIC POLYMYALGIA; RISK REDUCTION; SHORT SURVEY; SYMPTOM; TEMPORAL ARTERY; VISUAL IMPAIRMENT;

AGED; BLINDNESS; DISEASE MANAGEMENT; EARLY DIAGNOSIS; GIANT CELL ARTERITIS; GLUCOCORTICOIDS; HUMANS; PRACTICE GUIDELINES AS TOPIC; RHEUMATOLOGY; TEMPORAL ARTERIES; VISION DISORDERS;

EID: 77955314732     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2010.119     Document Type: Short Survey

References (10)

1. Gonzalez-Gay, M. A. et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 61, 1454-1461 (2009).
2. Gonzalez-Gay, M. A. et al. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore) 84, 269-276 (2005).
3. Caselli, R. J. & Hunder, G. G. Neurologic aspects of giant cell (temporal) arteritis. Rheum. Dis. Clin. North. Am. 19, 941-953 (1993).
4. Dasgupta, B. et al. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology (Oxford) doi:10.1093/ rheumatology/keq039a.
5. Salvarani, C. & Hunder, G. G. Giant cell arteritis with low erythrocyte sedimentation rate: frequency of occurence in a population-based study. Arthritis Rheum. 45, 140-145 (2001).
6. Gonzalez-Gay, M. A. et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum. 41, 1497-1504 (1998).
7. Achkar, A. A., Lie, J. T., Hunder, G. G., O'Fallon, W. M. & Gabriel, S. E. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann. Intern. Med. 120, 987-992 (1994).
8. Mahr, A. D. et al. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis. Arthritis Rheum. 56, 2789-2797 (2007).
9. Martinez-Taboada, V. M. et al. A double-blind placebo controller trial of etanercept in patients with giant cell arteritis and corticosteroids side effects. Ann. Rheum. Dis. 67, 625-630 (2008).
10. Salvarani, C. et al. Risk factors for severe cranial ischaemic events in an italian population-based cohort of patients with giant cell arteritis. Rheumatology (Oxford) 48, 250-253 (2009).